E-LIB Suche - Ergebnisse für: Quach, Hang

1

Daratumumab, cyclophosphamide, bortezomib and dexamethasone..:

Mollee, Peter ; Reynolds, John ; Janowski, Wojt...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

2

Recent Developments in Convenience of Administration of the..:

Quach, Hang ; Parmar, Gurdeep ; Mateos, Maria-Victoria..
Clinical Lymphoma Myeloma and Leukemia. , 2024

Link: https://doi.org/10.1016/..

3

Carfilzomib, thalidomide, and dexamethasone is safe and eff..:

Ninkovic, Slavisa ; Harrison, Simon J ; Lee, Je-Jung...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

4

Circulating tumour DNA analysis predicts relapse and improv..:

Mithraprabhu, Sridurga ; Reynolds, John ; Turner, Rose...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

5

PB2132: EXCALIBER-RRMM: A PHASE 3, TWO-STAGE STUDY OF IBERD..:

Lonial, Sagar ; Quach, Hang ; Dimopoulos, Meletios A....
HemaSphere. 7 (2023) S3 - p. e3132426 , 2023

Link: https://doi.org/10.1097/..

6

P906: GENOMIC ANALYSIS TO IDENTIFY DETERMINANTS OF INHERENT..:

Rodríguez-Otero, Paula ; Quach, Hang ; Weisel, Katja...
HemaSphere. 7 (2023) S3 - p. e041889f , 2023

Link: https://doi.org/10.1097/..

7

P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIEN..:

Bahlis, Nizar J ; Trudel, Suzanne ; Quach, Hang...
HemaSphere. 7 (2023) S3 - p. e7140563 , 2023

Link: https://doi.org/10.1097/..

8

Peripheral blood stem cell mobilisation following bortezomi..:

Sim, Shirlene ; Quach, Hang ; Pham, Tina..
Internal Medicine Journal. 54 (2023) 1 - p. 108-114 , 2023

Link: https://doi.org/10.1111/..

9

Final analysis of carfilzomib, dexamethasone, and daratumum..:

Usmani, Saad Z. ; Quach, Hang ; Mateos, Maria-Victoria...
Blood Advances. 7 (2023) 14 - p. 3739-3748 , 2023

Link: https://doi.org/10.1182/..

10

MM-360 Mezigdomide (MEZI) Plus Dexamethasone (DEX) in Relap..:

Orlowski, Robert Z. ; Bahlis, Nizar J. ; Quach, Hang...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S492-S493 , 2023

Link: https://doi.org/10.1016/..

11

MM-372 A Phase III, Two-Stage, Randomized Study of Mezigdom..:

Richardson, Paul G. ; Badelita, Sorina N. ; Besemer, Britta...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S495-S496 , 2023

Link: https://doi.org/10.1016/..

12

P-110 Ixazomib maintenance in transplant-ineligible patient..:

Dimopoulos, Meletios ; Chng, Wee Joo ; Iida, Shinsuke...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S95 , 2023

Link: https://doi.org/10.1016/..

13

P-305 DREAMM-20: a study to investigate the safety and effi..:

Quach, Hang ; Huang, Shang-Yi ; Lin, Hsuan-Yu...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S206 , 2023

Link: https://doi.org/10.1016/..

14

P-313 ALLG MM25 (VIBER-M): a phase Ib/II study of venetocla..:

Sim, Shirlene ; Solterbeck, Ann ; Forsyth, Cecily...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S210-S211 , 2023

Link: https://doi.org/10.1016/..

15

Australia and New Zealand consensus position statement: use..:

Campbell, Ashlea ; Teh, Benjamin ; Mulligan, Stephen...
Internal Medicine Journal. , 2023

Link: https://doi.org/10.1111/..